93315-49-2

Basic information

• Product Name: Quinoline, 2-methyl-8-(phenylmethoxy)-
• CAS NO: 93315-49-2
• Molecular Formula: C17H15NO
• Molecular Weight: 249.312
• Mol File: 93315-49-2.mol
• Article Data: 13

Chemical Properties

• CAS DataBase Reference: Quinoline, 2-methyl-8-(phenylmethoxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Quinoline, 2-methyl-8-(phenylmethoxy)-(93315-49-2)
• EPA Substance Registry System: Quinoline, 2-methyl-8-(phenylmethoxy)-(93315-49-2)

Safety Data

• Hazardous Substances Data: 93315-49-2(Hazardous Substances Data)

Upstream product

• 826-81-3 2-methyl-8-quinolinol 
• 100-44-7 benzyl chloride 
• 100-39-0 benzyl bromide 

Downstream Products

• 1593187-13-3 C₃₀H₃₀AuBr₂ClN₂O*CHCl₃ 
• 1593187-12-2 C₃₀H₃₁N₂O⁽¹⁺⁾*AgCl₂^(1-) 
• 1358916-57-0 2-(8-(benzyloxy)quinolin-2-yl)-1-(ethoxycarbonyl)cyclopropanecarboxylic acid 
• 1358916-54-7 diethyl 2-(8-(benzyloxy)quinoline-2-yl)cyclopropane-1,1-dicarboxylate 
• 1358916-49-0 diethyl 2-((8-(benzyloxy)quinoline-2-yl)methylene)malonate 
• 14510-06-6 2-formyl oxine 
• 176696-01-8 tris-N-[2-aminoethyl-(8-benzyloxyquinoline-2-carboxamido)]amine 
• 176696-00-7 8-hydroxyquinoline-2-carboxylic acid 
• 501911-49-5 8-benzyloxy-5-bromoquinoline-2-carbaldehyde 
• 501911-48-4 8-benzyloxy-5-bromo-2-methylquinoline 
• 88238-73-7 8-benzyloxyquinolin-2-yl-carboxaldehyde 

Relevant articles and documents

A novel quinoline derivative containing a phenanthroimidazole moiety: Synthesis, physical properties and light-emitting diodes application

The deep-blue emitting material 2-(8-(benzyloxy)quinolin-2-yl)-1-phenyl-1H-phenanthro[9,10-d]imidazole (QL-PPI) which contains 8-(Benzyloxy)quinoline core and phenanthroimidazole moiety, has been designed and synthesized. The non-doped OLED using QL-PPI a

Synthesis and evaluation of clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease

Considering the importance of PDE4D inhibition and the modulation of biometals in Alzheimer's disease (AD) therapeutics, we have designed, synthesized and evaluated a series of new clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands fo

MULTIFUNCTIONAL QUINOLINE DERIVATIVES AS ANTI-NEURODEGENERATIVE AGENTS

Novel quinoline derivatives are disclosed. Also disclosed are synthesis and use thereof for treating neurodegenerative diseases.